In addition to the various side effects observed with these treatments such as development of lymphomas, greater predisposition towards infection, re-exacerbation of latent tuberculosis, and problems related to autoimmunity [30], [37], systemically administered agents that affect the immune system most likely may/should not be used for cancer treatment as TNF is also needed for the proper functioning of the immune system. The gene discussed is TNF; the disease is cancer.